Trial Profile
A retrospective audit study assessing efficacy and safety of Azilsartan in hypertensive subjects in India (A real world RAAS-India study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2018
Price :
$35
*
At a glance
- Drugs Azilsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 16 Oct 2018 New trial record
- 09 Sep 2018 Results presented at the Hypertension Scientific Session 2018